Novavax (NVAX) Gross Margin (2011 - 2026)
Novavax (NVAX) posted quarterly Gross Margin of 78.0% for Q1 2026, down 1988.0% year-over-year from 4.13% in Q1 2025, and down 8.21% quarter-over-quarter from 84.98% in Q4 2025.
Novavax (NVAX) Gross Margin (2011 - 2026) Analysis & Trends
Novavax's Gross Margin history runs 11 years deep, the most recent figure standing at 78.0% for Q1 2026.
- In Q1 2026, Gross Margin fell 1988.0% year-over-year to 78.0%; the TTM figure through Mar 2026 stood at 83.16% (down 428.0% YoY), while the FY2025 annual figure was 93.5%, up 2322.0% from the prior year.
- Gross Margin for Q1 2026 stood at 78.0%, down from 84.98% in the prior quarter.
- The five-year high for Gross Margin was 97.88% in Q1 2025, with the low at 45.8% in Q2 2022.
- The 5-year median for Gross Margin is 58.48% (2024), against an average of 59.69%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin plunged 14580 bps in 2022, then jumped 13266 bps in 2023.
- Novavax's Gross Margin stood at 49.14% in 2022, then retreated by 5 bps to 46.81% in 2023, then advanced by 25 bps to 58.48% in 2024, then soared by 45 bps to 84.98% in 2025, then dropped by 8 bps to 78.0% in 2026.
- Business Quant data shows NVAX's Gross Margin at 78.0% in Q1 2026, 84.98% in Q4 2025, and 69.49% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 90.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 89.76% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 60,631,834.75% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 76.90% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 84.20% |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | 74.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.87% |
| Mar 31, 2026 | 78.00% |
| Dec 31, 2025 | 84.98% |
| Sep 30, 2025 | 69.49% |
| Jun 30, 2025 | 91.24% |
| Mar 31, 2025 | 97.88% |
| Dec 31, 2024 | 58.48% |
| Sep 30, 2024 | 28.27% |
| Jun 30, 2024 | 88.87% |
| Mar 31, 2024 | 36.91% |
| Dec 31, 2023 | 46.81% |
| Sep 30, 2023 | 47.09% |
| Jun 30, 2023 | 86.86% |
| Mar 31, 2023 | 57.89% |
| Dec 31, 2022 | 49.14% |
| Sep 30, 2022 | 40.84% |
| Jun 30, 2022 | -45.80% |
| Mar 31, 2022 | 97.84% |
| Dec 31, 2021 | 100.00% |
| Sep 30, 2021 | 100.00% |